DNV  Capital

Developing New Value

DNV  Capital

Developing New Value


DNV Capital, is an international venture capital firm focusing on the investments in healthcare and innovative technology industry.

DNV Capital concentrates on venture capital investment in start-up period and growth period, the directions of investment cover: medical treatment and health industry (including technology-leading pharmaceutic preparations, biological products, medical equipment and medical facilities; market-leading medical care providers, tele-medicine and health management) and innovative technology industry (including artificial intelligence (AI), Internet of Things, high-end robot, 3D printing, sensor and cloud computing).

DNV Capital is honored to be the member of Shenzhen Private Equity Association and Zhongguancun Private Equity& Venture Capital Association.


Managing Partner

Kevin Lin


Frank Wang


Zhe Yang


Joyce Lv



DNV Capital and ZTE Group Jointly Establish the [Denuowei] Series of Funds

In December 2021, DNV Capital, in collaboration with ZTE Weixiantong, officially established the [Denuowei] series of funds.



FiRe Convenes Selects TruTag as a 2017 Firestarter Company

Strategic News ServiceTM (SNS) has selected TruTag Technologies as a 2017 FiReStarter company to be featured at the 15th annual Future in Review (FiRe) Conference. FiRe 2017 will take place October 10-13 at the Stein Eriksen Lodge Deer Valley in Park City, Utah.

Kevin Lin was Awarded the Best Cross-border Investor on ChinaVenture-Hurun Midas List 2016

 Kevin Lin, founding manager of DNVCapital, was awarded the Best Cross-border Investor on ChinaVenture-Hurun Midas List 2016.